步长制药: 山东步长制药股份有限公司关于注销回购股份的实施公告

Group 1 - The company will cancel 51,474,203 repurchased shares, which accounts for a certain percentage of the total share capital before cancellation [1] - The cancellation date for the repurchased shares is set for August 12, 2025 [1] - The company initially approved a share repurchase plan on December 13, 2023, with a total fund amount between 180 million and 360 million yuan, later increased to between 360 million and 720 million yuan [1][2] Group 2 - As of May 9, 2025, the company had repurchased a total of 6,620,630 shares, representing 0.60% of the total share capital at that time, with a total payment of approximately 98.06 million yuan [1][2] - The company has undergone a series of board meetings to approve the change in the purpose of the repurchased shares to "reduce registered capital" [2][3] - The company has submitted the necessary applications for the cancellation of the repurchased shares to the Shanghai Stock Exchange [4] Group 3 - After the cancellation, the total number of shares will decrease from 1,106,042,645 to 1,054,568,442 [4] - The share structure will reflect the changes post-cancellation, with specific details to be confirmed by the China Securities Depository and Clearing Corporation [4]